Case report of adrenoleukodystrophy in a patient with familial adrenal insufficiency diagnosed and treated at 108 Military Central Hospital

  • Hoàng Thị Thủy Bệnh viện Trung ương Quân đội 108
  • Phạm Cẩm Diệu Linh Bệnh viện Trung ương Quân đội 108
  • Nguyễn Thị Thắm Bệnh viện Trung ương Quân đội 108
  • Nguyễn Thị Thanh Bé Bệnh viện Trung ương Quân đội 108

Main Article Content

Keywords

X-linked adrenoleukodystrophy, very long chain fatty acids

Abstract

Sex-linked ALD is a genetic disorder that occurs mainly in men, affecting the nervous system and adrenal glands. A 37-year-old male patient with a history of adrenal insufficiency at age 23, now regularly maintains hydrocortisone 10mg ´ 2 tablets/day. This time entered the hospital with symptoms of weakness of the extremities, difficulty walking, difficulty speaking, difficulty swallowing. Subclinical results showed that very long-chain fatty acids (VLCFA) increased, cortisol quantification decreased, magnetic resonance imaging of the brain with cerebellar myelin-type lesions, cerebral bridges, cerebral peduncles, and bilaterally symmetrical thalamus. Patients were diagnosed with adrenoleukodystrophy and treated for a regimen of fat reduction, correction of adrenal hormones and rehabilitation. The disease improves more clinical symptoms.

Article Details

References

1. Turk BR, Theda C, Fatemi A, Moser AB (2020) X‐linked adrenoleukodystrophy: Pathology, pathophysiology, diagnostic testing, newborn screening and therapies. Int J Dev Neurosci 80(1): 52-72.
2. Zhu J, Eichler F, Biffi A, Duncan CN, Williams DA, Majzoub JA (2020) The Changing Face of Adrenoleukodystrophy. Majzoub Endocr Rev 41(4): 577-593.
3. Benjelloun FZM, Kriouile Y, Cheillan D, Daoud-Tetouani H, Chabraoui L (2017) Management of X-linked adrenoleukodystrophy in Morocco: Actual situation. BMC Res Notes 10: 567.
4. Wiesinger C, Eichler FS, Berger J (2015) The genetic landscape of X-linked adrenoleukodystrophy: Inheritance, mutations, modifier genes, and diagnosis. Appl Clin Genet 8: 109-121.
5. Watkiss E, Webb T, Bundey S (1993) Is skewed X inactivation responsible for symptoms in female carriers for adrenoleucodystrophy. J Med Genet 30(8): 651-654.
6. Del Mastro RG, Bundey S, Kilpatrick MW (1990) Adrenoleucodystrophy: A molecular genetic study in five families. J Med Genet 27(11): 670-675.
7. Mallack EJ, Turk BR, Yan H, Price C, Demetres M, Moser AB, Becker C, Hollandsworth K, Adang L, Vanderver A, Van Haren K, Ruzhnikov M, Kurtzberg J, Maegawa G, Orchard PJ, Lund TC, Raymond GV, Regelmann M, Orsini JJ, Seeger E, Kemp S, Eichler F, Fatemi A (2021) MRI surveillance of boys with X-linked adrenoleukodystrophy identified by newborn screening: Meta-analysis and consensus guidelines. J Inherit Metab Dis 44(3): 728-739.
8. Honey MIJ, Jaspers YRJ, Engelen M, Kemp S, Huffnagel IC (2021) Molecular biomarkers for adrenoleukodystrophy: an unmet need. Cells 10(12): 3427.
9. Ryalls MR, Gan HW, Davison JE (2021) Adrenoleukodystrophy in the differential diagnosis of boys presenting with primary adrenal insufficiency without adrenal antibodies. J Clin Res Pediatr Endocrinol 13(2): 212-217.
10. Ronghe M, Barton J, Jardine P, Crowne E, Webster M, Armitage M, Allen J, Steward C (2022) The importance of testing for adrenoleucodystrophy in males with idiopathic Addison's disease. Arch Dis Child 86(3): 1850189.
11. Salsano E, Tabano S, Sirchia SM, Colapietro P, Castellotti B, Gellera C, Rimoldi M, Pensato V, Mariotti C, Pareyson D, Miozzo M, Uziel G (2012) Preferential expression of mutant ABCD1 allele is common in adrenoleukodystrophy female carriers but unrelated to clinical symptoms. Orphanet J Rare Dis. 7: 10.